Literature DB >> 7777273

Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy.

J D Gass1, H Little.   

Abstract

PURPOSE: To present evidence that systemic corticosteroid therapy may cause bilateral bullous serofibrinous exudative retinal detachment in some patients with idiopathic central serous chorioretinopathy.
BACKGROUND: Idiopathic central serous chorioretinopathy usually causes mild, transient loss of central vision, usually in otherwise healthy men with a type A personality. A few patients have permanent visual loss because of chronic and recurrent retinal detachment. The clinical findings in these patients may lead to incorrect diagnoses and use of corticosteroid therapy.
METHODS: The clinical and photographic records of three patients in whom bilateral bullous serofibrinous exudative retinal detachment associated with idiopathic central serous chorioretinopathy developed after treatment with systemic corticosteroids were reviewed.
RESULTS: Systemic corticosteroid treatment was instituted (1) as a prophylaxis to prevent exacerbation of the disease while undergoing surgery in the fellow eye, and (2) as the result of misdiagnoses of multifocal choroiditis and retinal vasculitis (Eales disease). Two of the patients had a history of chronic recurrent retinal detachments before institution of corticosteroid treatment. In one of these patients, bilateral chronic inferior retinal detachment developed, causing peripheral retinal vascular nonperfusion, retinal neovascularization, and vitreous hemorrhage. All three patients had severe permanent visual loss in one or both eyes.
CONCLUSION: The findings in these patients provide further evidence that systemic corticosteroid treatment may cause severe exacerbation of retinal detachment and lasting visual loss in some patients with idiopathic central serous retinopathy. Recognition of the atypical presentations of this disorder is important to avoid incorrect diagnoses and treatment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7777273     DOI: 10.1016/s0161-6420(95)30960-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  36 in total

1.  [Inferior retinal detachment with whitish subretinal lesion].

Authors:  H Helbig; C Valmaggia; H Niederberger
Journal:  Ophthalmologe       Date:  2003-12       Impact factor: 1.059

2.  Development of bullous retinal detachment during systemic corticosteroid treatment.

Authors:  Xinxiao Gao; Xiaoxin Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-12-03       Impact factor: 3.117

Review 3.  Central serous retinopathy associated with adrenocorticotrophic hormone therapy. A case report and a hypothesis.

Authors:  E Zamir
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-06       Impact factor: 3.117

4.  [Visual loss after pars plana vitrectomy with membrane peeling].

Authors:  M Schmidt; N Schrage; C Clemens; N Eter
Journal:  Ophthalmologe       Date:  2013-12       Impact factor: 1.059

5.  Surgical management of bilateral exudative retinal detachment associated with central serous chorioretinopathy.

Authors:  Ji Eun Kang; Hyun Jin Kim; Hee Don Boo; Ha Kyoung Kim; Jeong Hee Lee
Journal:  Korean J Ophthalmol       Date:  2006-06

6.  Obstructive sleep apnea and central serous chorioretinopathy.

Authors:  Frank L Brodie; Emily S Charlson; Tomas S Aleman; Rebecca T Salvo; Dina Y Gewaily; Marisa K Lau; Neil D Farren; Stephanie B Engelhard; Maxwell Pistilli; Alexander J Brucker
Journal:  Retina       Date:  2015-02       Impact factor: 4.256

7.  Acute Exudative Polymorphous Vitelliform Maculopathy Syndrome; natural history and evolution of fundal and OCT images over time.

Authors:  Patrick Murtagh; Maxwell Treacy; Kirk Stephenson; Ian Dooley
Journal:  BMJ Case Rep       Date:  2018-03-20

8.  Choroidal changes in eyes treated with high-dose systemic corticosteroids for optic neuritis.

Authors:  Jun Hyuk Lee; Ji Young Lee; Ho Ra; Nam Yeo Kang; Jiwon Baek
Journal:  Int J Ophthalmol       Date:  2020-09-18       Impact factor: 1.779

9.  Central serous chorioretinopathy in African Americans.

Authors:  Uday R Desai; Amir A Alhalel; Thomas J Campen; Rhett M Schiffman; Paul A Edwards; Gordon R Jacobsen
Journal:  J Natl Med Assoc       Date:  2003-07       Impact factor: 1.798

10.  Indocyanine green enhanced subthreshold diode-laser micropulse photocoagulation treatment of chronic central serous chorioretinopathy.

Authors:  F Ricci; F Missiroli; F Regine; M Grossi; G Dorin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-17       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.